Richard Green
Family · Bartlett, TNNPI 1366539728
Payments from drug & device makers
Across 507 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$1K
- AbbVie$1K
- Lilly USA, LLC$1K
- Abbott$721
- Bayer$534
- plus $3K from 25 others
What the payments were for
- Food & beverage$9,34599%
- Education$961%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 74 | $1,836 |
| Novo Nordisk | 61 | $1,145 |
| AbbVie | 92 | $1,021 |
| Lilly USA, LLC | 61 | $1,012 |
| Abbott | 36 | $721 |
| Bayer | 25 | $534 |
| Boehringer Ingelheim | 32 | $506 |
| Corcept Therapeutics | 9 | $418 |
| Pfizer | 15 | $311 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $299 |
| Amarin Pharma, Inc. | 11 | $194 |
| Tris Pharma Inc | 11 | $183 |
| Otsuka America Pharmaceutical, Inc. | 8 | $147 |
| Abiomed | 6 | $138 |
| Esperion Therapeutics, Inc. | 1 | $122 |
| LEO Pharma Inc. | 1 | $119 |
| Amgen | 7 | $109 |
| Nevro Corp. | 1 | $99 |
| GSK | 6 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $82 |
| Merck | 5 | $81 |
| Eisai Inc. | 4 | $72 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $44 |
| Cardiovascular Systems Inc. | 2 | $32 |
| Antares Pharma, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Boston Scientific | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Vistapharm, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
| Genentech USA, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$546
- Korlym$250
- BREZTRI$236
- Kerendia$224
- NEXLIZET$122
- NEXLETOL$122
- AIRSUPRA$118
- Quillichew ER$114
- Dyanavel XR$114
- Quillivant$114
How this compares
$9,442 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $28,426 |
| EliquisApixaban | 19 | $23,259 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $19,170 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $16,466 |
| FarxigaDapagliflozin Propanediol | 11 | $12,248 |
| JardianceEmpagliflozin | 11 | $11,456 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,136 |
| SynthroidLevothyroxine Sodium | 23 | $2,803 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 65 | $2,395 |
| Rosuvastatin Calcium | 104 | $1,495 |
| Novolog FlexpenInsulin Aspart | 14 | $1,370 |
| Atorvastatin Calcium | 172 | $1,313 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,279 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 23 | $1,205 |
| Omeprazole | 71 | $1,170 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Farxiga | $1,836 | $28,71333 claims |
| Novo NordiskOzempic | $1,145 | $28,42618 claims |
| PfizerEliquis | $311 | $23,25919 claims |
| Boehringer IngelheimJardiance | $506 | $11,45611 claims |
| GSKAnoro Ellipta | $96 | $5,13611 claims |
| AbbVieSynthroid | $1,021 | $2,80323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.
Other family in Bartlett
- Stacy ScrewsBartlett$58K
- Belinda PresleyBartlett$33K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.